These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7667399)

  • 1. Biological rhythms in the inflammatory response and in the effects of non-steroidal anti-inflammatory drugs.
    Labrecque G; Bureau JP; Reinberg AE
    Pharmacol Ther; 1995 May; 66(2):285-300. PubMed ID: 7667399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biological rhythm, inflammation and non-steroidal anti-inflammatory agents].
    Bureau JP; Labrecque G
    Pathol Biol (Paris); 1996 Sep; 44(7):610-7. PubMed ID: 8977918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clocking in: chronobiology in rheumatoid arthritis.
    Buttgereit F; Smolen JS; Coogan AN; Cajochen C
    Nat Rev Rheumatol; 2015 Jun; 11(6):349-56. PubMed ID: 25800214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of non-steroidal anti-inflammatory drugs on cardiovascular risk: Is it the same in osteoarthritis and rheumatoid arthritis?
    Bournia VK; Kitas G; Protogerou AD; Sfikakis PP
    Mod Rheumatol; 2017 Jul; 27(4):559-569. PubMed ID: 27659504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsteroidal therapy of rheumatoid arthritis and osteoarthritis: how physicians manage treatment failures.
    Spencer-Green G; Spencer-Green E
    J Rheumatol; 1998 Nov; 25(11):2088-93. PubMed ID: 9818649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are rheumatoid arthritis patients more willing to accept non-steroidal anti-inflammatory drug treatment risks than osteoarthritis patients?
    Bagge E; Traub M; Crotty M; Conaghan PG; Oh E; Brooks PM
    Br J Rheumatol; 1997 Apr; 36(4):470-2. PubMed ID: 9159542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and improved safety--a new anti-arthritic agent.
    Irani M
    Eur J Rheumatol Inflamm; 1991; 11(3):43-9. PubMed ID: 1365480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-arthritic agents: progress and potential.
    Laev SS; Salakhutdinov NF
    Bioorg Med Chem; 2015 Jul; 23(13):3059-80. PubMed ID: 26014481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nabumetone: a new NSAID for rheumatoid arthritis and osteoarthritis.
    Roth SH
    Orthop Rev; 1992 Feb; 21(2):223-7. PubMed ID: 1538889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
    Price-Forbes AN; Callaghan R; Allen ME; Rowe IF
    Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of cyclosporine A and nonsteroidal anti-inflammatory drugs on renal function in patients with rheumatoid arthritis.
    Altman RD; Perez GO; Sfakianakis GN
    Am J Med; 1992 Oct; 93(4):396-402. PubMed ID: 1415303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy for pain management in inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis).
    Ramiro S; Radner H; van der Heijde D; van Tubergen A; Buchbinder R; Aletaha D; Landewé RB
    Cochrane Database Syst Rev; 2011 Oct; (10):CD008886. PubMed ID: 21975788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cod liver oil (n-3 fatty acids) as an non-steroidal anti-inflammatory drug sparing agent in rheumatoid arthritis.
    Galarraga B; Ho M; Youssef HM; Hill A; McMahon H; Hall C; Ogston S; Nuki G; Belch JJ
    Rheumatology (Oxford); 2008 May; 47(5):665-9. PubMed ID: 18362100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy for pain management in inflammatory arthritis: a Cochrane systematic review.
    Ramiro S; Radner H; van der Heijde DM; Buchbinder R; Aletaha D; Landewé RB
    J Rheumatol Suppl; 2012 Sep; 90():47-55. PubMed ID: 22942329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Verification of a decision analytic model assumption using real-world practice data: implications for the cost effectiveness of cyclo-oxygenase 2 inhibitors (COX-2s).
    Cox ER; Motheral B; Mager D
    Am J Manag Care; 2003 Dec; 9(12):785-94. PubMed ID: 14712755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular adverse events by non-steroidal anti-inflammatory drugs: when the benefits outweigh the risks.
    Zingler G; Hermann B; Fischer T; Herdegen T
    Expert Rev Clin Pharmacol; 2016 Nov; 9(11):1479-1492. PubMed ID: 27575590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HZT-501 (DUEXIS(®); ibuprofen 800 mg/famotidine 26.6 mg) gastrointestinal protection in the treatment of the signs and symptoms of rheumatoid arthritis and osteoarthritis.
    Schiff M; Peura D
    Expert Rev Gastroenterol Hepatol; 2012 Feb; 6(1):25-35. PubMed ID: 22149579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian variations in the signs and symptoms of rheumatoid arthritis and in the therapeutic effectiveness of flurbiprofen at different times of day.
    Kowanko IC; Pownall R; Knapp MS; Swannell AJ; Mahoney PG
    Br J Clin Pharmacol; 1981 May; 11(5):477-84. PubMed ID: 7272159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overuse of prescription and OTC non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis and osteoarthritis.
    Cavagna L; Caporali R; Trifiro G; Arcoraci V; Rossi S; Montecucco C
    Int J Immunopathol Pharmacol; 2013; 26(1):279-81. PubMed ID: 23527735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small intestinal injury in NSAID users suffering from rheumatoid arthritis or osteoarthritis.
    Tachecí I; Bradna P; Douda T; Baštecká D; Kopáčová M; Rejchrt S; Lutonský M; Soukup T; Bureš J
    Rheumatol Int; 2016 Nov; 36(11):1557-1561. PubMed ID: 27549792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.